Intravitreal bevacizumab (Avastin) therapy versus photodynamic therapy plus intravitreal triamcinolone for neovascular age-related macular degeneration: 6-month results of a prospective, randomised, controlled clinical study (Q46731511)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Intravitreal bevacizumab (Avastin) therapy versus photodynamic therapy plus intravitreal triamcinolone for neovascular age-related macular degeneration: 6-month results of a prospective, randomised, controlled clinical study |
scientific article |
Statements
1 reference
Intravitreal bevacizumab (Avastin) therapy versus photodynamic therapy plus intravitreal triamcinolone for neovascular age-related macular degeneration: 6-month results of a prospective, randomised, controlled clinical study (English)
1 reference
G Weigert
1 reference
S Michels
1 reference
S Sacu
1 reference
A Varga
1 reference
F Prager
1 reference
W Geitzenauer
1 reference
U Schmidt-Erfurth
1 reference
1 March 2008
1 reference
1 reference
92
1 reference
3
1 reference
356-360
1 reference
Identifiers
1 reference
1 reference